Sponsor Pipeline

M.R. Meijerink Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06630624 Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM Colorectal Cancer Recruiting
NCT07595835 CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With… Pancreatic Cancer Recruiting
Disease Areas
Get alerts when M.R. Meijerink's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free